Patents by Inventor Hon Yu

Hon Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240415932
    Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.
    Type: Application
    Filed: August 26, 2024
    Publication date: December 19, 2024
    Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
  • Patent number: 12168038
    Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: December 17, 2024
    Assignee: VENTURIS THERAPEUTICS, INC.
    Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
  • Patent number: 11224635
    Abstract: Methods for the diagnosis and treatment of ischemic spinal conditions, degenerative disc disease, back pain and/or other tissue pathologies. Patients with ischemic spine disease can be categorized into subsets that are deemed to have potential to respond to therapy. In particular, therapies are disclosed which involve stimulation of neovascularization so as to increase perfusion of spinal and other anatomies.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: January 18, 2022
    Assignees: Venturis Thereuptics, Inc.
    Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri, Edwin Anderson
  • Publication number: 20200237873
    Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.
    Type: Application
    Filed: April 13, 2020
    Publication date: July 30, 2020
    Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
  • Patent number: 10624952
    Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: April 21, 2020
    Assignees: CardioVascular BioTherapeutics, Inc.
    Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
  • Publication number: 20150164994
    Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.
    Type: Application
    Filed: December 17, 2014
    Publication date: June 18, 2015
    Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
  • Patent number: 8983570
    Abstract: The invention relates to methods for the diagnosis, amelioration, and treatment of back pain, particularly lumbar back pain, in particular, back pain caused by muscular abnormalities, vertebral body osteoporosis, and disc degeneration. Patients with back pain are categorized into specific subsets that are deemed to have potential to respond to therapy. In particular, the invention includes a therapy involving stimulation of neovascularization so as to increase perfusion of various spine compartments.
    Type: Grant
    Filed: March 24, 2008
    Date of Patent: March 17, 2015
    Assignee: Cardiovascular Biotherapeutics, Inc.
    Inventors: Thomas J. Stegmann, Kenneth A. Thomas, John W. Jacobs, Tugan Muftuler, Shadfar Bahri, Hon Yu, Vance Gardner
  • Publication number: 20130230454
    Abstract: Methods for the diagnosis and treatment of ischemic spinal conditions, degenerative disc disease, back pain and/or other tissue pathologies. Patients with ischemic spine disease can be categorized into subsets that are deemed to have potential to respond to therapy. In particular, therapies are disclosed which involve stimulation of neovascularization so as to increase perfusion of spinal and other anatomies.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 5, 2013
    Applicant: CARDIOVASCULAR BIOTHERAPEUTICS, INC.
    Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri, Edwin Anderson
  • Publication number: 20090076481
    Abstract: The invention relates to methods for the diagnosis, amelioration, and treatment of back pain, particularly lumbar back pain, in particular, back pain caused by muscular abnormalities, vertebral body osteoporosis, and disc degeneration. Patients with back pain are categorized into specific subsets that are deemed to have potential to respond to therapy. In particular, the invention includes a therapy involving stimulation of neovascularization so as to increase perfusion of various spine compartments.
    Type: Application
    Filed: March 24, 2008
    Publication date: March 19, 2009
    Inventors: THOMAS J. STEGMANN, KENNETH A. THOMAS, JOHN W. JACOBS, TUGAN MUFTULER, SHADFAR BAHRI, HON YU, VANCE GARDNER
  • Patent number: 5353341
    Abstract: A cordless telephone arranged for operation in a frequency hopping system conserves battery power in a handset unit when this unit is located remote from an associated base unit and in a standby state. While in this standby state, the handset unit resides in a low power monitoring mode and monitors a channel pseudo-randomly selected from a plurality of available channels in the frequency hopping band for receipt of an initialization signal from the associated base unit. The base unit similarly monitors this selected one of the channels for receipt of this initialization signal from the handset unit. Should ongoing communications between the base unit and the handset unit be inadvertently interrupted, the cordless telephone quickly re-establishes communications in the frequency hopping system through an initialization process executed by both the handset unit and the base unit.
    Type: Grant
    Filed: October 21, 1991
    Date of Patent: October 4, 1994
    Assignee: AT&T Bell Laboratories
    Inventors: Mark E. Gillis, Kenneth W. Leland, William J. Nealon, Hon Yu
  • Patent number: 5323447
    Abstract: A cordless telephone arranged for operation in a frequency hopping system automatically modifies a frequency hopping sequence in the presence of interference detected on its in-use communication channels. Substitute alternative communication channels are identified and then substituted for those communication channels experiencing the interference without disruption of communications between a handset unit in the cordless telephone and its associated base unit.
    Type: Grant
    Filed: November 1, 1991
    Date of Patent: June 21, 1994
    Assignee: AT&T Bell Laboratories
    Inventors: Mark E. Gillis, Kenneth W. Leland, William J. Nealon, Hon Yu